Groupama Asset Managment »

Denali Therapeutics shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2024-03-31 $899k 44k 20.52
2023-12-31 $752k 35k 21.47